Use AI/ML to enhance patient classification and understanding of performance and opportunity.

Leverage patient cohort data to derive conclusions that matter for brands and businesses.

Mitigate biases along the patient journey to set real-world claims data as a source of truth for pharma companies.

Enriched data enhances segmentation, targeting, KPI tracking, forecasting and much more.

Estimate capture of various staging, biomarker and drug information to identify the gaps at a national and deeper level.

Use state-of-the-art machine learning techniques with real-world data sources and domain expertise to mitigate biases from data gaps.

Robust validation techniques including model robustness, business validations and deep desk research ensure insights can be integrated across the board.